about
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is eval...
Read More
123.63
3.62
(3.02%)
1.1M
XNAS Volume
XNAS 22 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Abivax (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..